These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16988411)

  • 1. Large-scale data management for high content screening.
    Garfinkel LS
    Methods Mol Biol; 2007; 356():281-91. PubMed ID: 16988411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of informatics for high content screening.
    Dunlay RT; Czekalski WJ; Collins MA
    Methods Mol Biol; 2007; 356():269-80. PubMed ID: 16988410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generating 'omic knowledge': the role of informatics in high content screening.
    Collins MA
    Comb Chem High Throughput Screen; 2009 Nov; 12(9):917-25. PubMed ID: 19531005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past, present, and future of high content screening and the field of cellomics.
    Taylor DL
    Methods Mol Biol; 2007; 356():3-18. PubMed ID: 16988391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmaceutical company user's perspective on the potential of high content screening in drug discovery.
    Hoffman AF; Garippa RJ
    Methods Mol Biol; 2007; 356():19-31. PubMed ID: 16988392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements, features, and performance of high content screening platforms.
    Gough AH; Johnston PA
    Methods Mol Biol; 2007; 356():41-61. PubMed ID: 16988394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High content screening as a screening tool in drug discovery.
    Nichols A
    Methods Mol Biol; 2007; 356():379-87. PubMed ID: 16988417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the integration of immunoreagents and fluorescent probes for multiplexed high content screening assays.
    Giuliano KA
    Methods Mol Biol; 2007; 356():189-93. PubMed ID: 16988403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and Opportunities in Enabling High-Throughput, Miniaturized High Content Screening.
    Nickischer D; Elkin L; Cloutier N; O'Connell J; Banks M; Weston A
    Methods Mol Biol; 2018; 1683():165-191. PubMed ID: 29082493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bio- and chemo-informatics beyond data management: crucial challenges and future opportunities.
    Stahura FL; Bajorath J
    Drug Discov Today; 2002 Jun; 7(11):S41-7. PubMed ID: 12047879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking microscopy and high content screening in large-scale biomedical research.
    Evans JG; Matsudaira P
    Methods Mol Biol; 2007; 356():33-8. PubMed ID: 16988393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the informatics framework in early lead discovery.
    Fay N
    Drug Discov Today; 2006 Dec; 11(23-24):1075-84. PubMed ID: 17129826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies and Solutions to Maintain and Retain Data from High Content Imaging, Analysis, and Screening Assays.
    Kozak K; Rinn B; Leven O; Emmenlauer M
    Methods Mol Biol; 2018; 1683():131-148. PubMed ID: 29082491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of high-content screening (HCS) technology and its importance to drug discovery.
    Fraietta I; Gasparri F
    Expert Opin Drug Discov; 2016; 11(5):501-14. PubMed ID: 26971542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international course on strategic information management for medical informatics students: aim, content, structure, and experiences.
    Haux R; Ammenwerth E; ter Burg WJ; Pilz J; Jaspers MW
    Int J Med Inform; 2004 Mar; 73(2):97-100. PubMed ID: 15063367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informatics in managed care: HIM adds value to data.
    Stratton SD
    J AHIMA; 2001 Sep; 72(8):58-62. PubMed ID: 15712483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise review: a high-content screening approach to stem cell research and drug discovery.
    Xia X; Wong ST
    Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informatics in clinical research in oncology: current state, challenges, and a future perspective.
    Chahal AP
    Cancer J; 2011; 17(4):239-45. PubMed ID: 21799332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in high content screening for drug discovery.
    Giuliano KA; Haskins JR; Taylor DL
    Assay Drug Dev Technol; 2003 Aug; 1(4):565-77. PubMed ID: 15090253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation.
    Haney SA
    Expert Opin Drug Discov; 2006 Jun; 1(1):19-29. PubMed ID: 23506030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.